These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9915040)

  • 1. Report from Working Group 3 (the Czech Republic, Denmark, Finland, Norway, The Netherlands, Slovakia, Sweden and the UK).
    Iwarson S
    Vaccine; 1998 Nov; 16 Suppl():S63-4. PubMed ID: 9915040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?
    Zuckerman J; van Hattum J; Cafferkey M; Gjørup I; Hoel T; Rummukainen ML; Weiland O
    Lancet Infect Dis; 2007 Jun; 7(6):410-9. PubMed ID: 17521594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal screening for hepatitis B among pregnant women led to 96% vaccination coverage among newborns of HBsAg positive mothers in Denmark.
    Harder KM; Cowan S; Eriksen MB; Krarup HB; Christensen PB
    Vaccine; 2011 Nov; 29(50):9303-7. PubMed ID: 22019756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cohesive European policy for hepatitis B vaccination, are we there yet?
    Lernout T; Hendrickx G; Vorsters A; Mosina L; Emiroglu N; Van Damme P
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():19-24. PubMed ID: 24829936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why the Scandinavian countries have not implemented universal vaccination against hepatitis B.
    Iwarson S
    Vaccine; 1998 Nov; 16 Suppl():S56-7. PubMed ID: 9915037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing epidemiology of hepatitis B and migration--a comparison of six Northern and North-Western European countries.
    Chu JJ; Wörmann T; Popp J; Pätzelt G; Akmatov MK; Krämer A; Reintjes R
    Eur J Public Health; 2013 Aug; 23(4):642-7. PubMed ID: 23132874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B vaccination coverage and risk factors associated with incomplete vaccination of children born to hepatitis B surface antigen-positive mothers, Denmark, 2006 to 2010.
    Kunoee A; Nielsen J; Cowan S
    Euro Surveill; 2016; 21(7):pii=30136. PubMed ID: 26923681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of hepatitis B immunization programmes in 1998.
    Kane MA
    Vaccine; 1998 Nov; 16 Suppl():S104-8. PubMed ID: 9915049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009?
    Mereckiene J; Cotter S; Lopalco P; D'Ancona F; Levy-Bruhl D; Giambi C; Johansen K; Dematte L; Salmaso S; Stefanoff P; O'Flanagan D
    Vaccine; 2010 Jun; 28(28):4470-7. PubMed ID: 20451643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress toward elimination of hepatitis B virus transmission in the United States.
    Mast EE; Mahoney FJ; Alter MJ; Margolis HS
    Vaccine; 1998 Nov; 16 Suppl():S48-51. PubMed ID: 9915035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of hepatitis B in the United Kingdom.
    Ramsay M; Gay N; Balogun K; Collins M
    Vaccine; 1998 Nov; 16 Suppl():S52-5. PubMed ID: 9915036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of educational inequality in the risk of stillbirth in Denmark, Finland, Norway and Sweden 1981-2000.
    Rom AL; Mortensen LH; Cnattingius S; Arntzen A; Gissler M; Andersen AM
    J Epidemiol Community Health; 2012 Mar; 66(3):240-6. PubMed ID: 20924053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational viral hepatitis in the Slovak and the Czech Republic.
    Buchancová J; Svihrová V; Legáth L; Osina O; Urban P; Fenclová Z; Zibolenová J; Rosková D; Murajda L; Hudecková H
    Cent Eur J Public Health; 2013 Jun; 21(2):92-7. PubMed ID: 24053065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public vaccination programmes against hepatitis B in The Netherlands: assessing whether a targeted or a universal approach is appropriate.
    Houweling H; Wittevrongel CF; Verweij M; Ruitenberg EJ;
    Vaccine; 2010 Nov; 28(49):7723-30. PubMed ID: 20933042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost of not implementing routine neonates immunization programmes in HBsAg high prevalence countries.
    Chauvin P; Ekra D; Plotkin SA
    Vaccine; 2002 Jul; 20(23-24):2848-50. PubMed ID: 12126893
    [No Abstract]   [Full Text] [Related]  

  • 16. The potential impact of improvements in contraception on fertility and abortion in Western countries.
    Westoff CF; Hammerslough CR; Paul L
    Eur J Popul; 1987 Nov; 3(1):7-32. PubMed ID: 12280731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ad hoc survey of hepatitis B vaccination campaign in newborns of HBsAg positive mothers and in 12-year-old subjects in southern Italy.
    Adamo B; Stroffolini T; Sagliocca L; Simonetti A; Iadanza F; Fossi E; Tancredi F; Mele A
    Vaccine; 1998 May; 16(8):775-7. PubMed ID: 9627934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scandinavian research in anaesthesiology 1981-2000: visibility and impact in EU and world context.
    Skram U; Larsen B; Ingwersen P; Viby-Mogensen J
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):1006-13. PubMed ID: 15315619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
    Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparing for the next public debate: universal vaccination against hepatitis B.
    Houweling H; Spaendonck MC; Paulussen T; Verweij M; Ruitenberg EJ
    Vaccine; 2011 Nov; 29(48):8960-4. PubMed ID: 21945254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.